UCA1 and breast cancer: Accumulating evidence revealed that UCA1 was dysregulated in cancer tissues and participated in the malignant progression of cancers, including bladder cancer, breast cancer, gastric cancer (GC), colorectal cancer (CRC) and lung cancer [9].